The Wall Street Journal
@WSJ
Sign up for our newsletters and alerts: | Got a tip? | For WSJ customer support:
加入 April 2007
1.1K 正在关注 22.3M 粉丝
Novo Nordisk agreed to license and develop the technology, which could cut the frequency patients need to inject its obesity and diabetes drugs.
